Examining the Genetic Factors That May Cause Chronic Obstructive Pulmonary Disease (COPD)

ClinicalTrials.gov ID: NCT00608764

Public ClinicalTrials.gov record NCT00608764. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Sep 23, 2026, 8:21 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Genetic Epidemiology of Chronic Obstructive Pulmonary Disease (COPDGene)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Chronic obstructive pulmonary disease (COPD) is a long-term lung disease that is often caused by cigarette smoking. The purpose of this study is to evaluate whether certain genetic factors predispose some smokers to develop COPD more than others.

Study identification

NCT ID: NCT00608764
Recruitment status: Active, not recruiting
Study type: Observational
Phase: Not listed
Lead sponsor: Brigham and Women's Hospital; Other
Enrollment: 10,718 participants

Conditions and interventions

Conditions

Interventions

Not listed

Eligibility (public fields only)

Age range: 45 Years to 80 Years
Sex: All
Healthy volunteers: Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Oct 31, 2007
Primary completion: Jul 31, 2028
Completion: Jul 31, 2028
Last update posted: Sep 16, 2025

2007 – 2028

United States locations

U.S. sites: 20
U.S. states: 13
U.S. cities: 17

Facility	City	State	ZIP	Site status
University of Alabama at Birmingham	Birmingham	Alabama	35249	—
University of California at San Diego	San Diego	California	92103	—
Los Angeles Biomedical Research Institute	Torrance	California	90502	—
National Jewish Health	Denver	Colorado	80206	—
Morehouse School of Medicine	Atlanta	Georgia	30310	—
University of Iowa	Iowa City	Iowa	52242	—
Johns Hopkins University	Baltimore	Maryland	21224	—
Brigham and Women's Hospital	Boston	Massachusetts	02115	—
Reliant Medical Group	Worcester	Massachusetts	01608	—
Ann Arbor VA Medical Center	Ann Arbor	Michigan	48105	—
University of Michigan	Ann Arbor	Michigan	48109	—
Minneapolis VA Medical Center	Minneapolis	Minnesota	55417	—
HealthPartners Research Foundation	Minneapolis	Minnesota	55440	—
University of Minnesota	Minneapolis	Minnesota	55455	—
Columbia University Medical Center	New York	New York	10032	—
Duke University	Durham	North Carolina	27710	—
Temple University	Philadelphia	Pennsylvania	19140	—
University of Pittsburgh	Pittsburgh	Pennsylvania	15232	—
Baylor College of Medicine	Houston	Texas	77030	—
University of Texas Health Sciences Center at San Antonio	San Antonio	Texas	78229	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT00608764, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Sep 16, 2025 · Synced Sep 23, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00608764 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →